Back to Agenda
Session 6: Patient Centricity
Session Chair(s)
Kathleen Salazar, MA, MBA
Head, Global Labeling Implementation
Johnson & Johnson Innovative Medicine, United States
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan
Pharmaceutical labeling contains important product information that helps enable appropriate prescribing decisions to be made, as well as the safe and effective use of prescribed products. With patients increasingly involved in their own healthcare decisions and outcomes, there is a need to develop patient-focused product information that is both understandable and accessible across a varied group of product end-users. This session will describe insights and approaches to creating patient centric pharmaceutical labeling and supporting development of health literacy across users of patient product information to help ensure engagement and understanding of patients who use our products.
Learning Objective : At the conclusion of this session, participants should be able to:
- Describe the opportunities and challenges of patient-centric drug labeling for all stakeholders
- Describe best practices in developing and implementing patient-centric drug labeling
- Describe the value of health literacy in creating effective patient-centered labeling
Speaker(s)
From Passive to Active: Patient-Centered Benefit-Risk Communication for Medicinal Products
Meredith Smith, PhD, MPA, FISPE
Evidera, Inc, United States
Senior Director, Implementation Science Pillar Lead
Patient Centric Labels in the US – Are We There Yet?
Kim Quaintance-Lunn
Bayer AG, United States
Vice President, Regulatory Affairs Americas
Health Literacy: Educating Patients Beyond the Label Itself, Impact of Labeling Development
Annlouise R Assaf, PhD, MS, FISPE
Pfizer Inc, United States
Senior Director, Patient Health Activation Expert
Focusing on Communication to the Patient: Australian and Canadian Patient Labeling
Hayley Parker, PhD, MSc
PepGen, United States
Vice President Regulatory Affairs
Have an account?